Literature DB >> 17418412

JUN oncogene amplification and overexpression block adipocytic differentiation in highly aggressive sarcomas.

Odette Mariani1, Caroline Brennetot, Jean-Michel Coindre, Nadège Gruel, Carine Ganem, Olivier Delattre, Marc-Henri Stern, Alain Aurias.   

Abstract

The human oncogene JUN encodes a component of the AP-1 complex and is consequently involved in a wide range of pivotal cellular processes, including cell proliferation, transformation, and apoptosis. Nevertheless, despite extensive analyses of its functions, it has never been directly involved in a human cancer. We demonstrate here that it is highly amplified and overexpressed in undifferentiated and aggressive human sarcomas, which are blocked at an early step of adipocyte differentiation. We confirm by cellular and xenograft mouse models recapitulating these sarcoma genetics that the failure to differentiate is dependent upon JUN amplification/overexpression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17418412     DOI: 10.1016/j.ccr.2007.02.007

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  72 in total

1.  Role of MSK1 in the malignant phenotype of Ras-transformed mouse fibroblasts.

Authors:  Beatriz Pérez-Cadahía; Bojan Drobic; Paula S Espino; Shihua He; Soma Mandal; Shannon Healy; James R Davie
Journal:  J Biol Chem       Date:  2010-11-10       Impact factor: 5.157

2.  Syntenic relationships between genomic profiles of fiber-induced murine and human malignant mesothelioma.

Authors:  Didier Jean; Emilie Thomas; Elodie Manié; Annie Renier; Aurélien de Reynies; Céline Lecomte; Pascal Andujar; Jocelyne Fleury-Feith; Françoise Galateau-Sallé; Marco Giovannini; Jessica Zucman-Rossi; Marc-Henri Stern; Marie-Claude Jaurand
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

Review 3.  Advances in sarcoma genomics and new therapeutic targets.

Authors:  Barry S Taylor; Jordi Barretina; Robert G Maki; Cristina R Antonescu; Samuel Singer; Marc Ladanyi
Journal:  Nat Rev Cancer       Date:  2011-07-14       Impact factor: 60.716

4.  c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.

Authors:  Stefano Sioletic; Jeffrey Czaplinski; Lan Hu; Jonathan A Fletcher; Christopher D M Fletcher; Andrew J Wagner; Massimo Loda; George D Demetri; Ewa T Sicinska; Eric L Snyder
Journal:  J Pathol       Date:  2014-08-01       Impact factor: 7.996

5.  Good COP1 or bad COP1? In vivo veritas.

Authors:  Wenyi Wei; William G Kaelin
Journal:  J Clin Invest       Date:  2011-03-14       Impact factor: 14.808

Review 6.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

7.  Maintaining a regular physical activity aggravates intramuscular tumor growth in an orthotopic liposarcoma model.

Authors:  Mohamad Assi; Frédéric Derbré; Luz Lefeuvre-Orfila; Dany Saligaut; Nathalie Stock; Mickael Ropars; Amélie Rébillard
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

8.  Cyclin D1 is a mediator of gastrointestinal stromal tumor KIT-independence.

Authors:  Wen-Bin Ou; Nan Ni; Rui Zuo; Weihao Zhuang; Meijun Zhu; Anastasios Kyriazoglou; Duolin Wu; Grant Eilers; George D Demetri; Haibo Qiu; Bin Li; Adrian Marino-Enriquez; Jonathan A Fletcher
Journal:  Oncogene       Date:  2019-08-01       Impact factor: 9.867

9.  Chromosomal changes in aggressive breast cancers with basal-like features.

Authors:  Wayne Yu; Yasmine Kanaan; Young Kyung Bae; Young-Kyung Baed; Edward Gabrielson
Journal:  Cancer Genet Cytogenet       Date:  2009-08

Review 10.  Palindromic gene amplification--an evolutionarily conserved role for DNA inverted repeats in the genome.

Authors:  Hisashi Tanaka; Meng-Chao Yao
Journal:  Nat Rev Cancer       Date:  2009-02-12       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.